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ABSTRACT 
Objective: The objective of this study was to analyze the current strategies used for eradicating wild polio viruses 
(WPV) and to propose some innovative strategies that may help to accelerate the progress towards polio eradication. 
Methods: We assessed the current strategies proposed by the World Health Organization, and the effectiveness of the 
current trivalent oral polio vaccine types 1, 2 and 3 (tOPV) schedule. Results: With the current schedule, tOPV is given 
four times to the child during his first year of life. After the four doses, 27%, 10% and 30% of children vaccinated are 
not immunized against WPV types 1, 2 and 3 respectively. In addition, low access to health care, insufficient funding of 
the routine immunization activities, and weak health systems hamper the tOPV coverage and the early detection of 
WPV cases for a rapid outbreak response. All these issues could explain the recurrence of WPV outbreaks, even in 
countries free of polio for many years. Therefore, we propose for countries of non-polio free regions, a new routine po- 
lio vaccination schedule composed of four doses of tOPV, followed by three doses of monovalent OPV type 1, and 
lastly by three doses of bivalent OPV types 1 and 3. With this schedule, of children fully vaccinated, 100%, 90% and 
99% will be immunized against WPV types 1, 2 and 3 respectively. In addition, adequate funding for routine immuni- 
zation activities and health system strengthening are proposed to accelerate the achievement of the polio eradication 
goal in a near future. Conclusions: The polio eradication goal is achievable. However, innovative strategies are urgen- 
tly needed to improve the effectiveness and the efficiency of the routine polio immunization program.  
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1. Introduction 
Significant efforts have been made so far along the path 
to polio eradication. After 23 years of Global polio eradi- 
cation initiative, a lot of improvement has been made in 
terms of reduction of wild polio virus (WPV) cases from 
350,000 estimated cases in 1988 to 1352 cases in 2010, 
DALYS and QUALYS earned and deaths averted [1]. 
Nigeria, the African country with the bulk of WPV cases 
in the past has made significant efforts, and has reduced 
WPV from 830 cases in 2005 to 21 cases in 2010. These 
global achievements are the results of the global partner- 
ship against polio, the improvement of the polio immu- 
nization coverage through routine vaccination and polio 
mass immunization campaigns, and of acute flaccid pa- 
ralysis (AFP) surveillance.  
With this significant reduction of WPV, there is in- 
creasing hope that the polio eradication goal can be 
achieved. The strategies used so far include routine vac- 
cination using trivalent oral polio vaccine types 1, 2 and 
3 (tOPV) for children under one year of age, and sup- 
plementary polio immunization mass campaigns through 
local, national, or regional immunization days using ei- 
ther tOPV, bivalent OPV types 1 and 3 (bOPV 1.3) or 
monovalent OPV type 1 (mOPV 1).  
In 2010, 12 (60%) of the 20 countries that reported 
WPV cases were from sub-Saharan Africa. These coun- 
tries notified 657 (49%) of the 1352 WPV cases reported 
worldwide. Other countries that notified WPV cases 
were Afghanistan, Pakistan, Kazakhstan, Russian Fed- 
eration, Tajikistan, Turkmenistan, Nepal and India [2]. 
With the resurgence of WPV cases in countries that had 
been free of polio for many years, it will be difficult to 
eradicate polio by the end of 2012 as planned, and inno- 
vative strategies are urgently needed to achieve this im- 
portant health goal [3].  
Therefore, we aim to identify the weaknesses of the 
strategies used so far, and to propose some innovative 
strategies to reinforce the battle against the WPV. This *Corresponding author. 
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may help to accelerate the progress towards polio eradi- 
cation in the coming years.  
2. Current Strategies Used for Eradicating 
Polio and Their Weaknesses 
Immunization programs consider children aged less than 
one year as the target group for routine vaccination. The 
objective of the polio administrative coverage is to reach 
at least 80%. The schedule for polio vaccination recom- 
mends 4 doses of tOPV given at birth, 6, 10 and 14 
weeks of age. In some countries, a recall dose of tOPV is 
recommended at 16 months of age. According to Grassly 
and colleagues [4], tOPV used in developing countries 
for routine polio immunization has a very low protective 
efficacy per dose—11% for tOPV compared to 30% for 
the mOPV1. Also, 14 doses of tOPV compared to 5 
doses of mOPV1 are required to protect 80% of children 
against WPV type 1. In Northern Nigeria, with one dose 
of mOPV1, 67% of children were protected while only 
16% of children were protected with one dose of tOPV 
[5]. In developing countries, after four doses of tOPV, 
73%, 90% and 70% of children are immunized against 
WPV types 1, 2 and 3 respectively [6]. Consequently, 
with this routine polio immunization schedule, 27%, 10% 
and 30% of children fully vaccinated are not immunized 
against WPV types 1, 2 and 3 respectively, and they 
could carry and spread the WPV in the community [7]. 
The surveillance of polio cases is based on AFP cases 
detection followed by stool examination for WPV identi- 
fication. Unfortunately, this AFP-based surveillance is 
not sensitive as only 0.1 to 1% of polio cases develop 
paralysis. In addition, the low access to health care, the 
false beliefs of the population concerning the child palsy, 
the poor quality of the health care, and the low involve- 
ment of private health providers, traditional healers and 
community leaders in AFP surveillance are others factors 
which hamper the early detection of WPV cases. 
The actual WHO policy concerning polio eradication 
is to respond against each detected WPV case by at least 
two rounds of polio mass immunization campaigns either 
at sub-national, national or regional level. Before a WPV 
infected child with AFP is detected, the WPV have all  
the time to spread among non-immunized children. These 
infected non-immunized children could excrete WPV in 
their stools for more than two months. With the high 
mobility of population within and between countries - 
mobile populations have also low access to immunization 
services, and the poor hygiene and sanitation, WPV 
could easily circulate even when polio mass immuniza- 
tion campaigns are organized. Neighboring countries of 
endemic or epidemic ones are therefore all at risk of 
hosting a dormant WPV circulation. Although these mass 
immunization campaigns may have a direct impact on 
polio immunization coverage, they are also known for 
their destructive effect on routine activities [8].  
Finally, the weak health systems in developing coun- 
tries have been also described as the major obstacle to 
the achievement of diseases control programs goals [9].  
3. Some Innovative Strategies 
In order to give a final boost to polio eradication, we 
suggest that the following policy issues and challenges 
should be taken into consideration by policymakers and 
Global health initiatives concerning immunization pro- 
grams in polio endemic regions.  
3.1. Review of the Immunization Schedule for 
Children under One Year of Age 
The schedule of routine polio vaccination should opti- 
mize the immunization of children against the three types 
of the WPV. Therefore, we propose that at birth, 6, 10 
and 14 weeks, tOPV should be given, followed at 18, 22 
and 26 weeks by mOPV 1, and then at 30, 34 and 40 
weeks by bOPV 1.3. Furthermore, at the end of each year, 
the number of children not immunized against polio dur- 
ing routine activities should be estimated to propose the 
best time for organizing supplementary polio immuniza- 
tion activities to maintain the herd immunity.  
The advantages of this schedule are 1) the immuniza- 
tion of 100%, 90% and 99% of children fully vaccinated 
against WPV types 1, 2 and 3 respectively. These protec- 
tion rates are sufficient to maintain high immunity among 
children and eradicate polio (Table 1); 2) the monthly 
follow-up of the child during his first year of life; and  
Table 1. Effectiveness of a routine polio vaccination schedule with four doses of tOPV, and three doses mOPV 1 and bOPV 1.3.  
Wild polio virus type 1 Wild polio virus type 2 Wild polio virus type 3 
Vaccine type Children  
Vaccinated 
Children 
immunized
Children
NIa 
Children 
Vaccinated
Children 
Immunized
Children 
NI 
Children  
Vaccinated 
Children 
immunized
Children 
NI 
tOPV 100b 73 27 100 90 10 100 70 30 
mOPV 1 27 26 1 10  10 30  30 
bOPV 1.3 1 1 0 10  10 30 29 1 
Overall program effectiveness 100 100 0 100 90 10 100 99 1 
aNot imm  unized; 
bAll the figures represent the number of children.  
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lastly 3) the reduction of the number of polio mass im- 
munization campaigns. 
In fact, with the current schedule, after 14 weeks, the 
child is seen much later, at 36 weeks, for measles and 
yellow fever vaccination. This long delay leads to a high 
drop-out for immunization and other child programs such 
as growth monitoring, breast feeding and nutrients sup- 
plementation.  
3.2. Adequate Funding for the Routine  
Immunization Activities 
Routine immunization activities should be adequately 
financed so that health facilities can easily cover their 
target population. The Reach Every District (RED) ap- 
proach based essentially on district immunization cover- 
age achievement should move to a child-based approach. 
With this approach, activities should be carefully planned 
by health facilities and the required resources adequately 
allocated so that all children are vaccinate using the three 
types of OPV before their first anniversary.  
3.3. Regular Identification of the Target  
Population for Routine Immunization 
The target population should come from a local census of 
children in each village/quarter, done by local people 
(community health workers for example). The poor ac- 
curacy of demographic data and the lack of regular cen- 
sus has led Expanded Program of Immunization’s man- 
agers to estimate the target population, with the propor- 
tion of children less than one year varying from one 
country to another (for example, 4% in Cameroon and 
2.95% in Cote d’Ivoire). The advantage of this census is 
that it can provide accurate data for monitoring routine 
immunization activities.  
3.4. Change from the Reach Every District (RED) 
Approach to the Reach Every Child Approach 
The RED approach aims to achieve routine immunization 
coverage objectives in each district should be trans- 
formed into a Reach Every Child (REC) approach. The 
objective of the REC approach will be to vaccinate each 
child during routine activities. Therefore, barriers to vac- 
cination should be regularly identified and addressed to 
improve access to immunization services in each basic 
administrative unit (village/quarter). Access to curative 
health care should be included in the immunization pro- 
grams’ strategies to improve the care of unhealthy chil- 
dren and more specifically of children with diseases pre- 
ventable by immunization. 
3.5. Implication of All Stakeholders in AFP  
surveillance and Health System Strengthening 
AFP surveillance should include all health providers es- 
pecially those of the private sector, traditional healers 
and the community health relays for a timely detection, 
investigation and reporting of AFP cases, and a timely 
response to WPV cases.  
The strengthening of the health system by immuniza- 
tion programs is mandatory and should not be limited to 
the immunization activities but should take into consid- 
eration the whole health care delivery system. Indeed, 
vertical programs including immunization programs ex- 
ert positive and negative effects on recipient health sys- 
tems—the latter could jeopardize the whole health care 
delivery [10]. Therefore, the interface between the im- 
munization program—as for all diseases control pro-
grams and the general health services should be regularly 
assessed to adapt both the program’s policy and health 
services strategies in order to create synergies and opti- 
mize the performance of the immunization program and 
general health services.  
4. Conclusion 
The current strategies have had a high impact in WPV 
cases reduction. However, recurrent polio outbreaks in 
endemic and non-endemic countries including those that 
had been free of polio for many years have delayed pro- 
gress towards eradication. Therefore, new and innovative 
strategies should be rapidly adopted, implemented and 
assessed for their scaling up. The adoption of a more 
effective routine polio immunization schedule should be 
the core content of these strategies.  
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